Literature DB >> 1364848

Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endothelium.

D Prieto1, S Benedito, U Simonsen, N C Nyborg.   

Abstract

1. Neuropeptide Y (NPY) induced a concentration-dependent contraction of isolated rings of proximal epicardial (PC) and distal intramural (DC) coronary arteries of the rat, with an EC50 of ca. 1 x 10(-7) M. The NPY-induced contraction at 3 x 10(-7) M was significantly smaller in PC than DC arteries: 34% vs. 55% of the 125 mM K(+)-induced response, respectively. 2. NPY (2 x 10(-8) M) increased the sensitivity to noradrenaline (NA) and 5-hydroxytryptamine (5-HT) more in PC (4.2 and 2.8 fold, respectively) than in DC arteries (2.2 and 1.4 fold, respectively). The maximal contractile response to NA and 5-HT was increased more in DC (43% and 29%, respectively) than in PC arteries (20% and 12%, respectively). 3. Removal of the endothelium increased the sensitivity and maximal response to NPY as well as the spontaneous myogenic tone in PC but not in DC arteries. NPY had no relaxing effect on PC and DC arteries submaximally contracted with 10(-6) M prostaglandin F2 alpha, suggesting that spontaneous rather than stimulated release of endothelium-derived relaxing factor (EDRF) depresses the contractile action of NPY in PC arteries. 4. The results indicate a heterogeneity in the contractile and potentiating action of NPY in rat coronary arteries depending on size or location in the coronary circulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1364848      PMCID: PMC1917921          DOI: 10.1111/j.1476-5381.1991.tb12245.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Potent effects of neuropeptide Y and calcitonin gene-related peptide on human coronary vascular tone in vitro.

Authors:  A Franco-Cereceda; J M Lundberg
Journal:  Acta Physiol Scand       Date:  1987-09

2.  Selective potentiation of extracellular Ca2+-dependent contraction by neuropeptide Y in rabbit mesenteric arteries.

Authors:  M Oshita; S Kigoshi; I Muramatsu
Journal:  Gen Pharmacol       Date:  1989

3.  Actions of neuropeptide Y on innervated and denervated rat tail arteries.

Authors:  T O Neild
Journal:  J Physiol       Date:  1987-05       Impact factor: 5.182

4.  Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig.

Authors:  J M Lundberg; X Y Hua; A Franco-Cereceda
Journal:  Acta Physiol Scand       Date:  1984-08

5.  Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.

Authors:  A Franco-Cereceda; J M Lundberg; C Dahlöf
Journal:  Acta Physiol Scand       Date:  1985-07

6.  Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide.

Authors:  J Gu; J M Polak; T E Adrian; J M Allen; K Tatemoto; S R Bloom
Journal:  Lancet       Date:  1983-05-07       Impact factor: 79.321

7.  Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.

Authors:  P Macho; R Pérez; J P Huidobro-Toro; R J Domenech
Journal:  Eur J Pharmacol       Date:  1989-08-11       Impact factor: 4.432

8.  Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.

Authors:  J Pernow
Journal:  Acta Physiol Scand Suppl       Date:  1988

9.  Neuropeptide Y is a vasoconstrictor of human coronary arteries.

Authors:  C J Tseng; D Robertson; R T Light; J R Atkinson; R M Robertson
Journal:  Am J Med Sci       Date:  1988-07       Impact factor: 2.378

10.  Studies on cardiac distribution and function of neuropeptide Y.

Authors:  J M Allen; P Gjörstrup; J A Björkman; L Ek; T Abrahamsson; S R Bloom
Journal:  Acta Physiol Scand       Date:  1986-03
View more
  6 in total

1.  Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries.

Authors:  Dolores Prieto; Luis Rivera de Los Arcos; Pilar Martínez; Sara Benedito; Albino García-Sacristán; Medardo Hernández
Journal:  Br J Pharmacol       Date:  2004-11-22       Impact factor: 8.739

2.  Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential.

Authors:  D Prieto; C Buus; M J Mulvany; H Nilsson
Journal:  J Physiol       Date:  1997-07-15       Impact factor: 5.182

3.  Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries.

Authors:  U Simonsen; D Prieto; L Rivera; M Hernández; M J Mulvany; A García-Sacristán
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

4.  Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.

Authors:  D Prieto; U Simonsen; N C Nyborg
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Expression of the human neuropeptide tyrosine Y1 receptor.

Authors:  J Wharton; L Gordon; J Byrne; H Herzog; L A Selbie; K Moore; M H Sullivan; M G Elder; G Moscoso; K M Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

Review 6.  The Biochemical Markers Associated with the Occurrence of Coronary Spasm.

Authors:  Liang Li; Yong-Ping Jin; Shu-Dong Xia; Chao Feng
Journal:  Biomed Res Int       Date:  2019-09-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.